Reaction

Central Sleep Apnoea Syndrome reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 315 reports · 8 co-occurring drugs

As of the last recalculation, Central Sleep Apnoea Syndrome appears in 315 FAERS reports alongside 8 co-occurring drug terms. The strongest observed disproportionality signal is CALCIUM, MAGNESIUM, POTASSIUM, AND SODIUM OXYBATES (PRR 235.7).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
DrugCo-reportsPRRROR
Calcium, Magnesium, Potassium, And Sodium Oxybates28235.7236.5
Valproic Acid2556.856.9
Brivaracetam752.652.6
Sodium Oxybate4552.552.5
Armodafinil1445.945.9
Naltrexone Hydrochloride And Bupropion Hydrochloride323.523.5
Buprenorphine2317.617.6
Lifitegrast416.416.4

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.